ALPS Medical Breakthroughs ETF (SBIO) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the ALPS Medical Breakthroughs ETF stock forecast from 0 analysts, the average analyst target price for ALPS Medical Breakthroughs ETF is not available over the next 12 months. ALPS Medical Breakthroughs ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of ALPS Medical Breakthroughs ETF is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, ALPS Medical Breakthroughs ETF’s stock price was USD 39.05. ALPS Medical Breakthroughs ETF’s stock price has changed by -5.27% over the past week, +1.24% over the past month and +54.78% over the last year.
No recent analyst target price found for ALPS Medical Breakthroughs ETF
No recent average analyst rating found for ALPS Medical Breakthroughs ETF
Company Overview ALPS Medical Breakthroughs ETF
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials. Read Less
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small...Read More
Frequently Asked Questions About ALPS Medical Breakthroughs ETF (SBIO) Stock
Stock Target Advisor's fundamental analysis for ALPS Medical Breakthroughs ETF's stock is Very Bearish.
SBIO stock's dividend yield is 0.19%.
Our analysis grades SBIO stock's dividend yield at F. This means that SBIO stock's dividend yield is above 25% of the stocks in the Health sector in the NYE exchange.
Based on this SBIO may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on SBIO's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on SBIO's stock to indicate if its overvalued.
The last closing price of SBIO's stock was USD 39.05.
The most recent market capitalization for SBIO is USD 0.13B.
Unfortunately we do not have enough analyst data on SBIO's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains ALPS Medical Breakthroughs ETF's stock.
Sorry, we do not have any data on the number of employees for ALPS Medical Breakthroughs ETF.
Sorry we do not have any infomation available on ALPS Medical Breakthroughs ETF's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Frequently Asked Questions About ALPS Medical Breakthroughs ETF (SBIO) Stock
Stock Target Advisor's fundamental analysis for ALPS Medical Breakthroughs ETF's stock is Very Bearish.
SBIO stock's dividend yield is 0.19%.
Our analysis grades SBIO stock's dividend yield at F. This means that SBIO stock's dividend yield is above 25% of the stocks in the Health sector in the NYE exchange.
Based on this SBIO may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on SBIO's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on SBIO's stock to indicate if its overvalued.
The last closing price of SBIO's stock was USD 39.05.
The most recent market capitalization for SBIO is USD 0.13B.
Unfortunately we do not have enough analyst data on SBIO's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains ALPS Medical Breakthroughs ETF's stock.
Sorry, we do not have any data on the number of employees for ALPS Medical Breakthroughs ETF.
Sorry we do not have any infomation available on ALPS Medical Breakthroughs ETF's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SBIO !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
